Chenguang Biotech: Net profit for the first three quarters is expected to increase by 344%-402% year-on-year.

Jin10 data reported on October 13 that Chenguang Biotech announced that it expects the net profit attributable to shareholders of the listed company for the first three quarters of 2025 to be between 278 million yuan and 314 million yuan, an increase of 344.05% to 401.55% compared to the same period last year. In the first three quarters of 2025, the revenue and gross profit of major plant extraction products achieved year-on-year growth, restoring profitability; the market for cottonseed-related businesses has warmed up, and the operating environment has significantly improved, achieving a return to profitability year-on-year, with the overall performance of the company rising compared to the same period last year.